CB&I awarded desulphur contract

• Publisher: Elsevier Science
• Year: 2004
• Tongue: English
• Weight: 35 KB
• Volume: 2004
• Category: Article
• ISSN: 1359-6128
• DOI: 10.1016/s1359-6128(04)00215-0

✦ Synopsis

CHEMICALS

COMPANIES TEAM UP TO DEVELOP BIO-CATALYSTS Dutch company DSM Pharma Chemicals (DPC) and US-based Diversa Corp have entered into a collaborative agreement to discover and develop bio-catalytic solutions for the production of single-enantiomer pharmaceutical intermediates and active ingredients for both new and existing pharmaceuticals.

Under the terms of the agreement, DPC will identify the intermediates and active ingredients that will be investigated, while Diversa will develop appropriate bio-catalysts. DPC will then scale up and commercialize the process.

According to DPC the use of biocatalysts often leads to less complex syntheses, lower production costs and more sustainable production processes because of the mild reaction conditions and reduced need for expensive or hazardous chemicals.